- Home
- LILAK vs QURE Comparison
LILAK vs QURE Comparison
Compare LILAK & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LILAK | QURE |
|---|---|---|
| Founded | 2017 | 1998 |
| Country | Bermuda | Netherlands |
| Employees | N/A | N/A |
| Industry | Cable & Other Pay Television Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.9B |
| IPO Year | N/A | 2007 |
Fundamental Metrics
Financial Performance| Metric | LILAK | QURE |
|---|---|---|
| Price | $8.52 | $20.42 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 12 |
| Target Price | $7.85 | ★ $58.55 |
| AVG Volume (30 Days) | 673.0K | ★ 2.4M |
| Earning Date | 11-05-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $4,433,000,000.00 | $15,751,000.00 |
| Revenue This Year | $1.62 | N/A |
| Revenue Next Year | N/A | $158.05 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.23 | $7.76 |
| 52 Week High | $9.13 | $71.50 |
Technical Indicators
Market Signals| Indicator | LILAK | QURE |
|---|---|---|
| Relative Strength Index (RSI) | 50.66 | 28.70 |
| Support Level | $8.35 | $20.55 |
| Resistance Level | $8.81 | $28.50 |
| Average True Range (ATR) | 0.27 | 1.35 |
| MACD | -0.03 | 0.23 |
| Stochastic Oscillator | 21.79 | 12.27 |
Price Performance
Historical ComparisonAbout LILAK Liberty Latin America Ltd. Class C
Liberty Latin America Ltd is a telecommunications company. It is a provider of video, broadband internet, fixed-line telephony, and mobile services to residential and business customers. The company's reportable segments include C&W Caribbean, Liberty Networks, C&W Panama, VTR, Liberty Puerto Rico and Liberty Costa Rica. The company generates the majority of its revenue from C&W Caribbean, and Liberty Puerto Rico segments.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.